Axon Enterprise (AXON)
(Delayed Data from NSDQ)
$281.67 USD
-0.06 (-0.02%)
Updated May 31, 2024 04:00 PM ET
After-Market: $281.35 -0.32 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$281.67 USD
-0.06 (-0.02%)
Updated May 31, 2024 04:00 PM ET
After-Market: $281.35 -0.32 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Zacks News
Resideo Technologies (REZI) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Resideo Technologies (REZI) delivered earnings and revenue surprises of 38.10% and 3.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Acco Brands (ACCO) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Acco (ACCO) delivered earnings and revenue surprises of 22.22% and 5.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Axon Enterprise (AXON) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 187.50% and 7.84%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Axon Enterprise (AXON) Q4 Earnings Expected to Decline
by Zacks Equity Research
Axon (AXON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Applied DNA Sciences (APDN) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -231.58% and 2.62%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Axon Enterprise (AXON) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 333.33% and 18.55%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Axon Enterprise (AXON) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Axon (AXON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)?
by Zacks Equity Research
Sector ETF report for XAR
JCI vs. AXON: Which Stock Is the Better Value Option?
by Zacks Equity Research
JCI vs. AXON: Which Stock Is the Better Value Option?
Axon Enterprise (AXON) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 72.73% and 26.42%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Industrial Stocks' Aug 5 Q2 Earnings Roster: BLL, AXON & More
by Madhurima Das
A brief look at what factors might drive the Q2 results of stocks like Ball Corp (BLL), Axon Enterprise (AXON), Terminix Global (TMX), Resideo Technologies (REZI) and Alarm.com Holdings (ALRM).
Axon Enterprise (AXON) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Axon (AXON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axon Enterprise (AXON) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 47.62% and 17.72%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Axon Enterprise (AXON) Q1 Earnings Expected to Decline
by Zacks Equity Research
Axon (AXON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Earnings Season Could Be Great for Axon Enterprise (AXON)
by Zacks Equity Research
Axon Enterprise (AXON) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Analyst Blog Highlights: Denbury, Axon Enterprise, Caterpillar, Scotts Miracle-Gro and Eastman Chemical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Denbury, Axon Enterprise, Caterpillar, Scotts Miracle-Gro and Eastman Chemical
Cyclical Sectors Gain Momentum in Early 2021: 7 Top Picks
by Nalak Das
We have narrowed down our search to seven cyclical stocks that have popped more than 10% year to date and still have upside left for 2021. These are: DEN, CFG, GS, AXON, EMN, CAT and SMG.
Flowserve (FLS) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Flowserve's (FLS) Q4 earnings are likely to have gained from signs of recovery in end markets, solid backlog and cost-control actions. Low demand due to the pandemic might have marred its performance.
Ingersoll (IR) to Post Q4 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Ingersoll Rand's (IR) Q4 earnings are likely to have gained from solid product portfolio, the Albin Pump buyout and cost-control actions. Unfavorable product mix might have marred its performance.
Axon Enterprise (AXON) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Axon (AXON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allegion (ALLE) Surpasses Q4 Earnings and Sales Estimates
by Zacks Equity Research
Allegion (ALLE) Q4 results reflect growth in sales and expansion in operating margin. Earnings for 2021 are predicted to decline year over year.
Allegion (ALLE) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Allegion's (ALLE) Q4 earnings are likely to have gained from solid product demand, strong residential business & healthy backlog. Low demand in Korea and Australia might have marred its performance.
ADT or AXON: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ADT vs. AXON: Which Stock Is the Better Value Option?
iRobot (IRBT) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
iRobot's (IRBT) Q4 earnings are likely to have gained from solid product demand, the holiday season and strong sales channels. However, high costs and expenses might have marred its performance.
II-VI (IIVI) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
II-VI's (IIVI) Q2 earnings are likely to have gained from the solid product demand, the Finisar buyout and strong sales channels. However, high costs and expenses might have marred its performance.